Past Conference Report

BIT's 11th Annual Congress of International Drug Discovery Science and Technology-2013 (IDDST2013), held in Hainan International Convention and Exhibition Center, China on November 13-16, achieved a consummation. The theme of this conference is 鈥淒iscovery for Happiness and Health". Over 350 honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are Mr. Qingang Hu, Vice-Chairman of Nanjing CPPCC, Deputy Chairman of Jiangsu Provincial Committee of China Zhi Gong Party, Chairman of Nanjing Municipal Committee of China Zhi Gong Party; Mr. Huabei Chen, Director, Information Research Center of International Talents, State Administration of Foreign Experts Affairs; Mr. Hailin Liu, Deputy Director-General, China Medicinal Biotech Association, China; Mr. Chun Wang, Vice-Director, Information Research Center of International Talents, State Administration of Foreign Experts Affairs; Dr. Xiaodan Mei, President of BIT Congress Inc.; Dr. Bruce A. Beutler, The Nobel Prize in Physiology or Medicine 2011, Professor and Director,Center for the Genetics of Host Defense, University of Texas, USA; Dr. Ei-ichi Negishi, The Nobel Prize in Chemistry 2010, Herbert C. Brown Distinguished Professor, Purdue University, USA; Dr. Akira Suzuki, The Nobel Prize in Chemistry 2010, Emeritus Professor, Hokkaido University, Japan; Dr. Aaron Ciechanover, The Nobel Prize in Chemistry 2004, Distinguished Research Professor, Technion-Israel Institute of Technology, Israel; Dr. Zhenping Zhu, Executive Vice President, Global Biopharmaceuticals, Kadmon Corporation, USA; Dr. Iwao Ojima, Distinguished Professor and Director, Stony Brook University-State University of New York, USA. Dr. Jamil Haddad, Vice President Global Sales, Jiangsu Hualan New Pharmaceutical Material Co., Ltd., Cina. More than 400 world-renowned experts, professors, laboratory principals, project leaders and representatives of well-known enterprises attended the conference.

This annual congress comprised 12 Streams and 37 sessions following the ceremony, including 鈥淐eremony, Award, Policy, Market Trendand Social Events"; "Frontiers of Drug Discovery Science and Technologies"; 鈥淏est Practice in Drug Discovery against Unmet Diseases"; 鈥淩ound Table and Panel Discussion on New Business Strategies Accelerating Drug Discovery"; "Young Investigator Forum and Posters Session"鈥tc.

This annual conference, brought together nearly 800 specialists from 37 countries and areas, was devoted to the leading issues and popular topics and provide up-to-date information to all over the world. On the other hand, the meeting provided a brilliant information platform for domestic researchers to communicate with international experts and pushed forward the drug discovery development. According to the investigation after the conference, most of our participants expressed that they would like to attend IDDST in the next year. Depending on the warmly support and good suggestions from all of the participants, we are quite confident in organizing IDDST-2014 which would be better and more successful than IDDST-2013. All of us are looking forward to meeting you again in 2014.
BIT鈥檚 4th World Gene Convention-2013 BIT鈥檚 4th Annual International Congress of Medichem-2013 BIT鈥檚 3rd Annual Symposium of Drug Delivery Systems-2013 BIT鈥檚 3rd Annual Congress of MolMed-2013 BIT鈥檚 1st Annual Symposium of Drug Designology-2013
  • Nobel Laureate Forum, Keynote Forum and Social Events
  • 17 Chapters Covering Major Hot Fields in Drug Discovery
  • Special Forums on National New Drug R & D and Market Trend Covering Most Countries and Regions
  • 1000+ Drug Innovators, Elites, Key Players, Investors and Decision Makers Who Make the Drug Discovery Decade, are Reunited
  • 50+ Exhibitors Showcasing the Emerging Methodologies and Technologies
  • 100+ Posters for Briefing the Current Drug Discovery Research
  • Bring your information to improve the success of your drug discovery research
  • Bring yourself up-to-date on current developments and future trends
  • Maximize your knowledge of the latest advances in the drug discovery areas
  • Do not miss the opportunity of meeting expert speakers representing leading organizations and companies
  • More Advanced-Level Sessions than Ever Before
  • Fresh Content: +30% New Sessions Offered in 2013
  • Special Networking Events: Meet and network with the key people working in the industry
  • Build academic and business collaboration
鈥淭he conference overall was very well done, covering many different aspects in drug product development that is of interest for the pharmaceutical sciences, industry and academia."
----by Dr. Sven Stegemann, Capsugel
鈥淚t is I who should thank you for a very enjoyable and informative conference and, most of all, for an impeccable organization and your remarkable hospitality."
----by Dr. Francois IRIS, Bio-Modeling Systems
鈥淚 enjoyed to contribute to the success of the conference and also intended to participate the next conference in Hainan. 鈥
----by Dr. Rolf Werner, Eberhard Karls University of Tuebingen
鈥淭hank you for hosting this conference. I enjoyed it very much and my talk was well-received. I also enjoyed meeting you and your colleagues."
----by Dr. Luana Pesco Koplowitz, DUCK FLATS Pharma, LLC.

Title: Forward Genetic Analysis of Innate Immune Sensing and Response

Dr. Bruce A. Beutler

Professor and Director,Center for the Genetics of Host Defense, University of Texas, USA
The Nobel Prize in Physiology or Medicine 2011

Prize Motivation: "For discoveries concerning the activation of innate immunity"


Title: Magical Power of Transition Metals: Past, Present and Future

Dr. Ei-ichi Negishi
Herbert C. Brown Distinguished Professor, Purdue University, USA
The Nobel Prize in Chemistry 2010
Prize Motivation: "For palladium-catalyzed cross couplings in organic synthesis"

Title: Cross-coupling Reactions of Organoboranes: An Easy Way for Carbon-carbon Bonding Useful for Synthesis of Pharmaceuticals

Dr. Akira Suzuki
Emeritus Professor, Hokkaido University, Japan
The Nobel Prize in Chemistry 2010

Prize Motivation: "For palladium-catalyzed cross couplings in organic synthesis"


Title: Personalized Medicine 鈥 are we going to cure all diseases and at what price?

Dr. Aaron Ciechanover
Distinguished Research Professor, Technion-Israel Institute of Technology, Israel
The Nobel Prize in Chemistry 2004

Prize Motivation: "For the discovery of ubiquitin-mediated protein degradation"


Over 500 highly respected industrialists and academic, key regulators and management gurus will speak at this four-day congress. The congress hereby invites groups and individuals to submit proposals for sessions (i.e. keynote & plenary lectures, symposia, workshops, etc.) for the scientific program. Interest groups are also welcome to organize independent pre- or post-congress Satellite meetings, which is different from session proposals for the program.
The conference offers a variety of co-sponsorship and exhibition packages, customized to meet your company's needs. Contact us today to secure your place at this year's conference!
Participating as an exhibitor or sponsor will provide you excellent exposure and network with 500 decision makers! The conference offers a customized package to meet your company's needs.

Dr. Shintaro Nishimura, Vice President, Bioimaging Research Laboratories, Astellas Pharma Inc., Japan

Dr. Cynthia O. Siu, Vice President, Data Power (DP), Inc, USA

Dr. Lieven Meerpoel, Senior Director, Head of MedChem Oncology, Johnson & Johnson Pharmaceutical Research & Development, Belgium Dr. Iwao Ojima, Distinguished Professor, Director, Stony Brook University - State University of New York, USA
Dr. Reinhard Wetzker, Professor, Institute for Molecular Cell Biology School of Medicine, Friedrich Schiller University Jena, Germany Dr. Xiaoyan Jiang, Senior Scientist and Associate Professor, Department of Medical Genetics, University of British Columbia, Canada Dr. Christian Gr酶ndahl, Executive Vice President, Chief Scientific Officer, Head of Research & Development, Zealand Pharma, Denmark Dr. Rolf G. Werner, Professorship for Industrial Biotechnology, Eberhard Karls University of Tuebingen, German
Dr. Michael T. Bowers, Professor, Department of Chemistry and Biochemistry, University of California, Santa Barbara, USA Dr. David F. Woodward, Senior Director, Department of Biological Sciences, Allergan Inc., USA Dr. Peter Koulen, Professor, Department of Basic Medical Science, University of Missouri-Kansas City, USA Dr. Jagat R. Kanwar, Professor, NLIMBR, Deakin University, Australia
Dr. Karol Jackowski, Full Professor of Chemistry, Laboratory of NMR Spectroscopy, Warsaw University, Poland Dr. Xianbin Yang, Director, Research and Development, Am Biotechnologies, LLC, USA Dr. Udo Maier, Head of Target Discovery Research, Boehringer Ingelheim Pharma AG, Germany Dr. Wolfgang Sadee, Professor of Pharmacy, Psychiatry and Medical Genetics, Ohio State University, USA
Dr. Luana Pesco Koplowitz, President, Chief Medical and Scientific Officer, DUCK FLATS Pharma, LLC., USA Dr. Christopher R. Triggle, Professor, Departments of Medical Education and Pharmacology, Weill Cornell Medical College in Qatar, Qatar Dr. Kathryn Uhrich, Professor and Dean, Mathematical & Physical Sciences, Rutgers University, USA Dr. Walter E Muller, Professor, University Frankfurt Biocenter, Germany
Dr. Alan Xiao, Director, Clinical Pharmacology and DMPK at AstraZeneca, USA Dr. Ping Wang, Professor, QM medical school, University of London, UK Dr. Susan M. MacDonald, Professor, Department of Medicine, The Johns Hopkins University School of Medicine, USA Dr. May Orfali,Senior Director, Rare Diseases Department, Pfizer, USA
Dr. Anfan Wu, Senior Director, Head of Early Development, Roche R&D Center, China Dr. Wim J Riedel, Vice President of Science, Clinical Trial and Academic Research Division, Cambridge Cognition Ltd, UK Dr. Jian Wu, Distinguished Professor, Fudan University Shanghai Medical College, China Dr. Cassandra L. Smith, Professor, Biomedical Engineering, Boston University, USA
Dr. George Garibaldi, Global Head of Neuroscience Development, F. Hoffmann-La Roche, Switzerland Dr. Pierre-Marc Bouloux, Professor, Royal Free and University College Medical School, University College London, UK Dr. Richard J. Whitley, Professor, Department of Medicine, The University of Alabama at Birmingham, USA Dr. John P.M. Finberg, Professor, Department of Molecular Pharmacology, Rappaport Faculty of Medicine, Technion, Israel


State Administration Of Foreign Experts Affairs
Haikou Municipal Government
China Medicinal Biotech Association
Information Research Center of International Talent, SAFEA
Haikou Convention and Exhibition Bureau
BIT Congress Inc.
Foreign Experts Databank of SAFEA-Dalian Biotechnological and Medical Experts Subdivision
Computational and Structural Biotechnology Journal
BIT World Travel Service, Inc.
漏 2012-2013 All right reserved by BIT Congress Inc.
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629